You are here

Mohali

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.
We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

The following position is available in Project No. GP-396 entitled, “Stereoselective Synthesis of Chiral Alcohols of Pharmaceutical Importance via Microbial Oxidoreductases: Process Development and Scale-up” sponsored by Ministry of Science and Technology, Department of Biotechnology, New Delhi in the Department of Pharmaceutical Technology (Biotechnology).

The National Institute of Pharmaceutical Education and Research has been established under the aegis of Ministry of Chemicals and Fertilizers, Government of India, Dept. of Pharmaceuticals as a Centre of Excellence in imparting higher education, research and development in pharmaceutical sciences and is the first Institute of its kind in country. The Institute was declared as an Institute of National Importance by Government of India through an Act of Parliament, notified on 26th June 1998. The Institute is a member of the Association of Indian Universities and Association of Commonwealth Universities.

Abstract:
Von Hippel-Lindau (VHL) syndrome is a rare genetic neoplastic disorder, arising from germline mutations in the VHL gene, characterized by the development of visceral cysts, specific benign and malignant tumors in multiple organ systems that have subsequent potential for spiteful change. It is caused by point mutations or deletions in a tumor suppressor gene. A tumor suppressor gene is the one which keeps cells from growing and dividing too rapidly in an uncontrolled way. Mutations in this gene prevent production of the VHL protein or lead to the production of an abnormal version of the protein. An altered or missing VHL protein cannot effectively regulate cell survival and division. As a result, cells grow and divide uncontrollably to form tumors and cysts that are characteristic of Von Hippel-Lindau syndrome. Although there is great variation in the clinical presentation, those who have a mutated gene are at greatly increased risk of developing spinal hemangioblastoma, renal cell carcinoma (RCC), retinal hemangioblastoma, cerebellar hemangioblastoma, pheochromocytoma, pancreatic and renal cysts, endolymphatic sac tumors, hemangiomas of the adrenals, liver and lungs, and papillary cystadenoma of the epididymis or broad ligament. The age at which the tumors present ranges from early childhood to the seventh decade of life. Early diagnosis, screening of family members and lifelong surveillance of VHL patients is recommended.

The National Institute of Pharmaceutical Education & Research (NIPER), S.A.S. Nagar (Mohali) is an autonomous Institute of National Importance set up by the Government of India, Ministry of Chemicals & Fertilizers by an Act of Parliament, to impart higher education and undertake advanced research in the field of Pharmaceutical Sciences, Technology and Management. The Institute intends to fill the following posts:

National Agri-Food Biotechnology Institute (NABI), Mohali, is an autonomous R&D Institute under the Department of Biotechnology, Government of India. The institute carries out cutting edge research at the interface of food, nutrition and agricultural biotechnology.

Applications are invited for the position of a Junior Research Fellow (JRF) under a DST sponsored research project in the Agricultural Biotechnology Research Programme at NABI.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

We take great pleasure in informing you that the Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education & Research (NIPER), S.A.S. Nagar (Mohali), Punjab, india is organizing 11th Annual Conference of International Society for Heart Research (Indian Section) which will be held from February 8-9, 2014.

National Agri-Food Biotechnology Institute (NABI), Mohali, is an autonomous R&D Institute under Department of Biotechnology, Government of India. The institute carries out cutting edge research at the interface of agricultural biotechnology, bioinformatics, biostatistics, food processing, postharvest technology, and nutritional sciences.

Abstract:
Neurofibromatosis is genetic disease characterized by lesions mainly in brain region with a broad array of complications associated with it. The prime role of treatment is to obtain a relief from the symptoms associated this disease.

The National Institute of Pharmaceutical Education and Research (NIPER) has been created as a centre of excellence for higher education, research and development in pharmaceutical sciences. NIPER, Rae Bareli at ITI campus, Rae Bareli under the mentoring Institute of Central Drug Research Institute, Lucknow invites eligible candidates for following positions on purely temporary basis on contract initially for a period of 1 year which can be extended further.